Name: グラボノイド
Brand: カネカユアへルスケア株式会社
Availability: Discontinued

A60

グラボノイド

カネカユアへルスケア株式会社

販売休止中

加工食品(錠剤、カプセル剤等)

Functional Claim

本品には3％グラブリジン含有甘草抽出物を含みます。3％グラブリジン含有甘草抽出物は、お腹の脂肪（内臓脂肪）をはじめとする体脂肪を減らすことをサポートし、高めのBMIの改善に役立つことが報告されています。本品は体脂肪・BMIが高めの方におすすめします。

AI Summary

Automatically generated from notification documents

This functional food contains licorice extract with 3% glabridin, which has been reported to support the reduction of body fat, including visceral fat, and to help improve a high BMI.

Key Features

[

"

S

u

p

o

r

t

s

v

i

s

c

e

r

a

l

f

a

t

r

e

d

u

c

t

i

o

n

"

,

"

H

e

l

p

s

i

m

p

r

o

v

e

h

i

g

h

B

M

I

"

,

"

C

o

n

t

a

i

n

s

g

l

a

b

r

i

d

i

n

"

]

For individuals concerned about body fat or a high BMI.

Recommended Products

PR

広告: A8.net

Notification Documents

Product Name	グラボノイド
Category
Food Classification	加工食品(錠剤、カプセル剤等)
Functional Ingredient Name	3％グラブリジン含有甘草抽出物
Functional ingredient is an extract	No
Functional Claim	本品には3％グラブリジン含有甘草抽出物を含みます。3％グラブリジン含有甘草抽出物は、お腹の脂肪（内臓脂肪）をはじめとする体脂肪を減らすことをサポートし、高めのBMIの改善に役立つことが報告されています。本品は体脂肪・BMIが高めの方におすすめします。
Consumer Affairs Department Contact
Information Disclosure Website URL

1. Basic Safety Information

(1) Precautions for Intake
(2) Safety Evaluation Method
(3) Notifier's Safety Evaluation

2. Production, Manufacturing & Quality Control

Details

3. Basic Functionality Information

(1) Functionality Evaluation Method
(2) Notifier's Functionality Evaluation

4. Other Notification Items

Reason for not classifying as tablet/capsule food
Primary Target Audience
Planned Sales Start Date
Change History (before Mar 31, 2025)
Change History (from Apr 1, 2025)
Before/After Comparison Table
Before/After Comparison Table (attachments)
If re-notification	No
Existing Notification Number
Reason for Maintaining Identity
Post-notification Sales Status	販売休止中
Reason for Notification Withdrawal

5. Self-Inspection Report

Month of Last Self-Inspection Report